Header Logo

Connection

LOIS M RAMONDETTA to Sirolimus

Back to Details
This is a "connection" page, showing publications LOIS M RAMONDETTA has written about Sirolimus.
LOIS M RAMONDETTA
Connection Strength
0.065
Sirolimus
  1. A phase 2 study of the oral mammalian target of rapamycin inhibitor, everolimus, in patients with recurrent endometrial carcinoma. Cancer. 2010 Dec 01; 116(23):5415-9.
    View in: PubMed
    Score: 0.065
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.